Research article · 17 Jul 2026
Conference abstractPublished 12 Nov 2013
The evolution of the medical device 510 (k) process and impending changes
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Medical devices play a critical role in the health care of Americans. They span a range from simple tools, such as dental floss and bandages, to complex or life-saving equipment, such as pacemakers, magnetic resonance imaging machines, and heart-lung machines. The Federal Food, Drug, and Cosmetic Act (FD&C Act) requires a "reasonable assurance of safety and effectiveness" before a device can be marketed, and the U.S. Food and Drug Administration (FDA) is responsible for enforcing this requirement. Devices that are deemed to have a moderate risk to patients generally cannot go on the market until they are cleared through the 510(k) process. This is the process by which most medical devices reach the market. Also known as ?premarket notification,? the 510(k) process has been subject to a considerable amount of criticism in the last several years. Claims that it is both too rigorous and not rigorous enough have been made, and legislators are ordering the US Food and Drug Administration (FDA) to scrap planned changes to the 510(k) process in favor of one yet to be built. This session discusses the legislative evolution of the 510(k) process, the perceived need for major change to the process and the controversy resulting from the impending change.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Developing Drugs.
Commentary · 4 Feb 2026
Vaccine Development and Global Disease Prevention
Commentary · 4 Feb 2026
Transforming Drug Development Through Pharmaceutical Biotechnology
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Developing Drugs
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Jacqueline McCulloch”
